跳至主要内容
临床试验/NCT06015633
NCT06015633进行中(未招募)不适用

Exploration of Ocular, Vascular, and Genetic Findings Associated and Correlated with the Presence of Late-stage AMD

OcuDyne, Inc.1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年10月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
50
试验地点
1
主要终点
OCT-A

研究概览

简要总结

Observation of findings associated with AMD

详细描述

Explorational observation of ocular, vascular, and genetic findings in patients diagnosed with AMD

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 55 years of age at the time of consent
  • Able to understand and provide written informed consent
  • Sufficiently clear ocular media, adequate pupillary dilation, and adequate fixation to permit quality fundus imaging
  • Able to cooperate with ophthalmic visual function testing and anatomic assessments
  • Diagnosed with late-stage AMD in at least one eye. (if both eyes of an eligible subject meet inclusion criterion, the more advanced eye will receive primary eye assignment)
  • Willing to have protocol specified genetic testing
  • Willing to have head coil MRI/A (with contrast if deemed necessary)

排除标准

  • History of any retinal disease other than AMD in either eye
  • Spherical equivalent refractive error demonstrating >6 diopters of myopia or an axial length >26 mm in the study eye
  • History of vitrectomy in the study eye
  • Any intraocular surgery (including lens replacement surgery) in the study eye, within 90 days of enrollment
  • History of endophthalmitis
  • Trabeculectomy or aqueous shunt or valve in the study eye
  • Aphakia or absence of the posterior capsule in the study eye (Note: Previous violation of the posterior capsule is also excluded unless it occurred as a result of yttrium aluminum garnet [YAG] laser posterior capsulotomy in association with prior posterior chamber intraocular lens implantation and at least 90 days prior to enrollment)
  • Presence of advanced guttae or visually significant keratopathy that would cause scattering of light or alter visual function in the study eye
  • History of idiopathic or autoimmune-associated uveitis in either eye
  • Active inflammation or infection, including conjunctivitis, keratitis, or scleritis in either eye
  • GA secondary to a condition other than AMD (e.g., Stargardt's disease, cone rod dystrophy, or toxic maculopathies such as Plaquenil maculopathy) in either eye
  • Use of any investigational product or investigational medical device (i.e., not approved by FDA for the specific use) within 90 days prior to screening or anticipated use during the study
  • Women of childbearing potential who are pregnant or unwilling to use effective contraception for the duration of the study
  • Acute or serious illness, in the opinion of the site investigator
  • History of kidney failure or gadolinium toxicity

结局指标

主要结局

OCT-A

时间窗: Baseline observation of incidence / correlation only

OCT-A metrics in subjects with AMD

次要结局

  • Magnetic Resonance Angiography(Baseline observation of incidence / correlation only)
  • Genetic markers related to AMD(Baseline observation of incidence / correlation only)

研究者

发起方
OcuDyne, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验